Published in Cancer Weekly, November 8th, 2005
According to recent research from France, "Many cutaneous side-effects of long-term use of hydroxyurea therapy are well-known. We report the first case, to our knowledge, of a neuroendocrine carcinoma located on the finger associated with other cutaneous changes due to this drug."
"Our patient received HU for 2 years for a thrombocytemia. This treatment was stopped because of a dermatomyositis-like eruption. Two years later, she developed multiple keratotic lesions, and 8 years later, a Merkel cell carcinoma on the third left finger with metastasic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.